Ocular Therapeutix is a biopharmaceutical company based in Waltham, MA, that focuses on developing innovative treatments for retinal diseases, glaucoma, ocular surface diseases, and ophthalmic surgery. They are dedicated to enhancing people's vision and quality of life through consistent and sustainable drug delivery, utilizing their versatile ELUTYX technology platform to create sustained-release therapies for various ocular conditions.
The company is actively involved in clinical trials and research to develop preservative-free, sustained-release implants as an alternative to repeated injections for retinal diseases, biodegradable hydrogel alternatives to daily eye drops for glaucoma, and sustained-release inserts for lasting treatment without preservatives for ocular surface diseases. With a commitment to transforming treatments in postoperative care, Ocular Therapeutix is investigating their innovative ELUTYX technology. As a rapidly growing company, they offer exciting career opportunities and comprehensive benefits for talented individuals.
Generated from the website